<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169577/" ref="ordinalpos=75&amp;ncbi_uid=3224233&amp;link_uid=PMC3169577" image-link="/pmc/articles/PMC3169577/figure/pone-0024152-g001/" class="imagepopup">Figure 1. Basic overview of TGF-Î² <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Evolution of the TGF-? <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> and Its Potential Role in the Ctenophore, Mnemiopsis leidyi. </a></div><br /><div class="p4l_captionBody">Binding of a ligand to a Type II receptor initiates signaling. The sequestering of a Type I receptor results in the activation of a Receptor-Smad (Smad1/5, Smad2/3). Together with the Co-Smad (Smad4), this complex enters the nucleus and activates the transcription of target genes. The pathway can be inhibited by extracelluar antagonists, or intracellularly via Inhibitor-Smad (Smad6/7) or the ubiquitin ligase SMURF.</div></div>